Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Elubrixin tosylate (SB-656933 tosylate) is a high-potency, selective, competitive, and reversible CXCR2 antagonist, as well as an antagonist of the IL-8 receptor. It effectively inhibits upregulation of neutrophil CD11b (with an IC50 of 260.7 nM) and shape change (with an IC50 of 310.5 nM). This compound holds promise for the study of inflammatory diseases, including inflammatory bowel disease and airway inflammation.
Description | Elubrixin tosylate (SB-656933 tosylate) is a high-potency, selective, competitive, and reversible CXCR2 antagonist, as well as an antagonist of the IL-8 receptor. It effectively inhibits upregulation of neutrophil CD11b (with an IC50 of 260.7 nM) and shape change (with an IC50 of 310.5 nM). This compound holds promise for the study of inflammatory diseases, including inflammatory bowel disease and airway inflammation. |
In vitro | Elubrixin has an inhibitory effect on neutrophils in a dose-dependent fashion[1]. |
Synonyms | SB-656933 tosylate, Elubrixin tosylate |
Molecular Weight | 635.5 |
Formula | C24H25Cl2FN4O7S2 |
CAS No. | 960495-43-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Elubrixin tosylate 960495-43-6 SB-656933 tosylate SB-656933 Tosylate Elubrixin Tosylate SB656933 Tosylate SB 656933 Tosylate inhibitor inhibit